Medpace Holdings, Inc. - 8-K Filing

Medpace Holdings reports Q3 2026 revenue of $716.0 million and announces new $1.0 billion stock repurchase authorization. (Items: 2.02 Results of Operations and Financial Condition, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $MEDP

Read the full article at SEC EDGAR

More Regulatory news